Obiettivo del fondo

The investment objective of the Sub-Fund is to provide capital appreciation over the long term. The Sub-Fund seeks to achieve its objective by investing in a diversified portfolio of global equity securities of companies involved in the medical technology ecosystem that can demonstrate their ability to comply with international sectoral standards for ESG. In actively managing the Fund, the Investment Manager will invest at least 75% of its net assets in equity and equity-linked securities of any country, without constraints of capitalization. Among this proportion of 75% of its assets, the Sub-Fund may invest in China A shares via Stock Connect within a maximum of 25% of its assets. The Sub-Fund may use derivatives for hedging, investment purposes and/or efficient portfolio management. The Sub-Fund is actively managed. There can be no guarantee that the investment objective will actually be attained. Investors can redeem their Shares on any Business Day, as defined in the supplement. Investors can ask for full or partial redemption of the Shares held. SFDR Classification : The Sub-Fund is classified as an Article 8 financial product under SFDR. For more detailed information on the ESG components of the Sub-Fund as well as the integration of sustainability risks into the investment decision process, please refer to the supplement and to the ICAV prospectus. Benchmark Information : The Investment Manager has selected the MSCI World Health Care Equipment and Supplies 10/40 Index NR (“Index”) that will be used as a comparison for the investment performance only. The Investment Manager does not intend to replicate the composition of such Index and may at all times exercise total freedom by investing in securities which are not included in the referenced Index or which are present in different proportions

Documenti